Trial Profile
Phase-I Randomized, Open Label, Crossover Food-Effect and Absolute Bioavailability Study of WCK 2349 and WCK 771 in Healthy Adult Human Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Alalevonadifloxacin (Primary) ; Levonadifloxacin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- 21 Sep 2015 Results (Food Effect and Absolute Bioavailability) presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 30 Jun 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.